Neuroone Medical Technologies (NMTC) Finished Goods (2022 - 2026)

Neuroone Medical Technologies (NMTC) has reported Finished Goods for 5 consecutive years, with $784812.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Finished Goods rose 1.14% year-over-year to $784812.0; the trailing twelve-month figure through Jun 2026 stood at $784812.0 (up 1.14% YoY), and the FY2025 full-year result was $1.2 million, down 21.75% from the prior year.
• Finished Goods rose to $784812.0 in Q2 2026 per NMTC's latest filing, from $721343.0 in the prior quarter.
• Across five years, Finished Goods topped out at $1.6 million in Q3 2024 and bottomed at $73968.0 in Q3 2022.
• Historically, Finished Goods has averaged $679547.1 across 5 years, with a median of $712322.5 in 2024.
• The sharpest annual moves came in 2024 and 2025: Finished Goods surged 768.35% in 2024, then tumbled 41.11% in 2025.
• Over 5 years, Finished Goods stood at $73968.0 in 2022, then surged by 143.47% to $180092.0 in 2023, then soared by 388.62% to $879966.0 in 2024, then sank by 41.11% to $518209.0 in 2025, then soared by 51.45% to $784812.0 in 2026.
• According to Business Quant data, Finished Goods over the past three periods registered $784812.0, $721343.0, and $518209.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.